New Rheumatoid Arthritis Treatments for ‘Old’ Patients: Results of a Systematic Review

INTRODUCTION: In the last 20 years, biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs) have become available for treating rheumatoid arthritis (RA), and a treat-to-target strategy has been introduced. We hypothesise that these advances should have resulted in changes to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Caporali, Roberto, Fakhouri, Walid K. H., Nicolay, Claudia, Longley, Harriet J., Losi, Serena, Rogai, Veronica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444401/
https://www.ncbi.nlm.nih.gov/pubmed/32705531
http://dx.doi.org/10.1007/s12325-020-01435-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444401/
https://www.ncbi.nlm.nih.gov/pubmed/32705531
http://dx.doi.org/10.1007/s12325-020-01435-6

Ejemplares similares